Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Fijnheer

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Blood|February 1, 2012
The macrophage mannose receptor promotes uptake of ADAMTS13 by dendritic cellsNicoletta Sorvillo, Wouter Pos, Linda M van den Berg, et al.
Clinical Kidney Journal|June 12, 2015
Preemptive dosage reduction of nadroparin in patients with renal failure: a retrospective case seriesMarije Russcher, Nienke Josephus Jitta, Rob J Kraaijenhagen, et al.
American Journal of Hematology|April 9, 2014
Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphomaHugo J A Adams, Thomas C Kwee, Rob Fijnheer, et al.
Blood|May 10, 2007
beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregationJanine J J Hulstein, Peter J Lenting, Bas de Laat, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|August 23, 2015
Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effectsHugo Ja Adams, John Mh de Klerk, Rob Fijnheer, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 13, 2014
Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?Hugo J A Adams, Thomas C Kwee, Rob Fijnheer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2013
FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysisHugo J A Adams, Thomas C Kwee, Bart de Keizer, et al.
European Journal of Haematology|December 25, 2014
Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevanceHugo J A Adams, Thomas C Kwee, Rob Fijnheer, et al.
Blood|January 10, 2016
CD4+ T cells from patients with acquired thrombotic thrombocytopenic purpura recognize CUB2 domain-derived peptidesFabian C Verbij, Annelies W Turksma, Femke de Heij, et al.
Journal of Computer Assisted Tomography|April 1, 2014
Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?Hanneke P van Hamersvelt, Thomas C Kwee, Rob Fijnheer, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Blood|February 1, 2012
The macrophage mannose receptor promotes uptake of ADAMTS13 by dendritic cellsNicoletta Sorvillo, Wouter Pos, Linda M van den Berg, et al.
Clinical Kidney Journal|June 12, 2015
Preemptive dosage reduction of nadroparin in patients with renal failure: a retrospective case seriesMarije Russcher, Nienke Josephus Jitta, Rob J Kraaijenhagen, et al.
American Journal of Hematology|April 9, 2014
Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphomaHugo J A Adams, Thomas C Kwee, Rob Fijnheer, et al.
Blood|May 10, 2007
beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregationJanine J J Hulstein, Peter J Lenting, Bas de Laat, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|August 23, 2015
Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effectsHugo Ja Adams, John Mh de Klerk, Rob Fijnheer, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 13, 2014
Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?Hugo J A Adams, Thomas C Kwee, Rob Fijnheer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 28, 2013
FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysisHugo J A Adams, Thomas C Kwee, Bart de Keizer, et al.
European Journal of Haematology|December 25, 2014
Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevanceHugo J A Adams, Thomas C Kwee, Rob Fijnheer, et al.
Blood|January 10, 2016
CD4+ T cells from patients with acquired thrombotic thrombocytopenic purpura recognize CUB2 domain-derived peptidesFabian C Verbij, Annelies W Turksma, Femke de Heij, et al.
Journal of Computer Assisted Tomography|April 1, 2014
Can full-dose contrast-enhanced CT be omitted from an FDG-PET/CT staging examination in newly diagnosed FDG-avid lymphoma?Hanneke P van Hamersvelt, Thomas C Kwee, Rob Fijnheer, et al.
Pageof 11